News By Tag
* Lee Biosolutions
* More Tags...
News By Place
Lee Biosolutions Human Salivary Amylase production increased to meet worldwide demand
Lee Biosolutions’ extensive human donor program allows them to process over 500 liters of human saliva per year for their human salivary amylase production requirements for IVD manufacturers and clinical researchers.
According to Lee Biosolutions President Burton Lee, human salivary amylase
“We operate with one ear constantly tuned to the research community,” Lee said. “This helps us stay on top of the latest research being conducted, and gives us the information we need to stay ahead of their demands.”
Salivary Amylase enzyme is the only enzyme in saliva capable of degrading oligosaccharides , which are used by the oral microflora for nutritional purposes. Because human salivary amylase can act anywhere on the substrate, human alpha-amylase enzyme tends to be faster acting than beta-amylase enzyme.
Human alpha amylase is primarily classified into two kinds of isoenzymes. S-type amylase comes from salivary glands and P-type amylase from the pancreas. The company offers both types of isoenzymes in research and bulk quantities, and has the capabilities to custom purify human alpha amylase in a wide variety of buffers.
Lee Biosolutions is a leader in the biomarker industry, providing quality products to clinical labs and researchers around the world, developing tomorrow’s cures. For more information or to place an order, contact :
Lee Biosolutions, Inc
2924 Mary Ave
St. Louis, MO 63144
# # #
Lee Biosolutions, Inc specializes in the development and purification of high quality BioMarkers for the Immunodiagnostic, clinical diagnostic and pharmaceutical industry worldwide. We supply reliable high quality human and animal enzymes and proteins, cardiac markers, tumor markers, acute phase proteins, coagulation proteins and immunoassay biomarkers.